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Abstract
Despite the well-known relevance of comorbidity, few studies have examined the impact of
comorbid anxiety or externalizing symptoms on the prevention of depressive symptoms in
adolescents. To replicate earlier positive effects of a cognitive-behavioral prevention program of
depressive symptoms and to test the hypothesis that the prevention program would be less
effective in adolescents with comorbid anxiety and externalizing symptoms, a study was
conducted involving 301 8th-grade students, randomly divided into an intervention group and a
non-intervention control group. The randomized design included baseline, post-intervention, and
6-month follow-up. The prevention program included 10 sessions held in a regular school
setting. The prevention program showed positive effects on depressive symptoms, independent
of comorbid symptoms. These effects were found mainly with girls independent of their
depressive symptoms at baseline, and in part with boys with less severe depressive symptoms at
baseline. Surprisingly, negative effects of the prevention program on depressive symptoms were
found on the depression of boys with more severe depressive symptoms at baseline. The
prevention program’s low rate of attrition and high recruitment rate support the generalizability
of the results.

Keywords: depressive symptoms; adolescents; comorbid symptoms; school-based universal
prevention
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According to epidemiological studies, 15% to 20% of children and adolescents experience at
least one depressive episode before adulthood (Birmaher et al., 1996). The consequences of the
early development of depressive disorders may persist for years after adolescence. Depressive
symptoms at a young age also increase the probability of major depression (e.g., Weissman et al.,
1999) and other psychopathologies later in life (Birmaher et al., 1996). Even so-called
“subsyndromal depression” is a serious risk factor for depressive episodes in youth or later in life
(Georgiades, Lewinsohn, Monroe, & Seeley, 2006; Lewinsohn, Solomon, Seeley, & Zeiss,
2000). In response to the high incidence and negative long-term effects of depressive symptoms
and major depression in children and adolescents, different researchers have developed universal
prevention programs that can be applied to a general population regardless of individual risk (for
a review of the advantages and disadvantages of different types of prevention programs, see
Offord, 2000; Pössel, 2005).
Four cognitive-behavioral, school-based universal prevention programs of depressive
symptoms for adolescents have emerged from different labs. All but one have shown some
positive effects by preventing the development of depressive symptoms or reducing the increase
of an already existing depressive symptomatology (Merry, McDowell, Wild, Bir, & Cunliffe,
2004; Pössel, Horn, Groen, & Hautzinger, 2004; Shochet et al., 2001; Spence, Sheffield, &
Donovan, 2003, 2005). Only one prevention program (Clarke, Hawkins, Murphy, & Sheeber,
1993) showed no effect at all on the depressive symptomatology of participating adolescents.
To the best of our knowledge, no study has focused on the impact of comorbid problems on
the prevention of depressive symptoms in adolescents. This is surprising given that it has been
estimated that 40% to 90% of depressed adolescents have at least one comorbid disorder
(Angold, Costello, & Erkanli, 1999), the most frequent being anxiety, oppositional defiant
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disorder, and conduct disorder (e.g., Costello, Mustillo, Erkanli, Keeler, & Angold, 2003). Some
studies, however, found that these disorders affected the impact of psychotherapy on depressive
adolescents. Based on empirical findings, most psychopathologies can be seen as existing on a
continuum from subthreshold symptoms to diagnosable mental disorders (e.g. depression; see
Flett, Vredenburg & Krames, 1997). Drawing from these studies, we may develop hypotheses
about how comorbid symptoms might influence the effects of prevention programs.
So far, four studies have focused on the impact of comorbid anxiety on cognitive-behavioral
therapy with depressed adolescents. In one of these studies, Clarke et al. (1992) noted that a
higher score in state anxiety was connected with higher depression scores in a post-intervention
trial. In another study focusing on a post-intervention trial, Reinecke (2005) reported a similar
effect of comorbid anxiety disorders on a clinician-rating of depressive symptoms. In a study
performed by Brent and colleagues (Brent, Kolko, Birmaher, Baugher, & Bridge, 1999; Brent et
al., 1998), however, comorbid anxiety disorders were correlated with lower rates of recovery; no
influence of comorbid anxiety on required additional psychotherapy could be shown in a postintervention measure. Moreover, Rohde, Clarke, Lewinsohn, Seeley, and Kaufman (2001)
reported no influence of anxiety disorders on the recovery of major depression. Instead, their
results showed a greater decrease of self-reported depression scores from baseline to postintervention measurement in adolescents with lifetime anxiety disorders than in patients without
lifetime anxiety. In later 24-month follow-ups, no connection between comorbid anxiety and
depression was found, independent of the outcome variable (Brent et al., 1999; Rohde et al.,
2001; Weersing & Weisz, 2002). Although the pattern of results is somewhat mixed, it suggests
that while anxiety may reduce the short-term effect of psychotherapy for depressed adolescents,
it has no influence on follow-up effects.
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Common basic maladjustments may explain this pattern of results. For example, depression
and anxiety can be explained by dysfunctional emotional regulation and negative affectivity
(Clark & Watson, 1991). These maladjustments can cause inadequate regulations of emotions
and an inability to cope with negative events. Another risk factor of depression and anxiety is the
so-called “behavioral inhibition” in social situations, which includes symptoms such as shyness,
withdrawal behavior, inhibited communication, and anxiousness in unfamiliar and unpleasant
situations (Muris, Merckelbach, Schmidt, Gadet, & Bogie, 2001). To reduce these symptoms of
depression, effective cognitive-behavioral therapy addresses such maladjustments. Nevertheless,
the existence of comorbidity may be the expression of a more generalized maladjustment
compared to adolescents with only one disorder. If so, the ratio between maladjustment and
intervention dose in adolescents with comorbidity at the end of psychotherapy might be less
positive than in patients with only one disorder. This could explain the lower short-term effects
in adolescents with comorbid depression and anxiety. In the long run, however, we expect
adolescents participating in cognitive-behavioral therapy to be able to generalize the use of their
new abilities to other situations. As such we believe that these adolescents will be more likely to
address the common basic maladjustments of depression and anxiety. After the conclusion of
cognitive-behavioral therapy, participants may experience a reduction of their depressive
symptoms.
In addition to the studies previously mentioned six studies have focused on the impact of
externalizing problems on cognitive-behavioral therapy and its subsequent influence on
depression (Brent et al., 1999; Reinecke, 2005; Rohde et al., 2001; Rohde, Clarke, Mace,
Jorgensen, & Seeley, 2004; Rohde, Jorgensen, Seeley, & Mace, 2004; Weersing & Weisz, 2002).
None of these studies reported an effect of conduct disorder, oppositional deviant disorder, or a

Impact of comorbidity on prevention

6

combination of both on the outcome of therapy with depressed adolescents in pre-post
comparisons. In the follow-ups, however, three studies showed that externalizing problems
increase the recurrence of major depression (Rohde et al., 2001), reduce the likelihood of
recovery from major depression (Rohde, Clarke et al., 2004), and increase the amount of
required additional therapy (Brent et al., 1999) after a course of cognitive-behavioral
psychotherapy. Two studies, on the other hand, reported no effect of externalizing problems on
self-reported depressive symptoms (Weersing & Weisz, 2002) and recovery from major
depression (Rohde et al., 2001) after therapy. In summary, while externalizing problems may
have no short-term effects on the therapy outcomes of depressed adolescents, they may have a
negative influence on depression in the follow-ups.
One explanation for this pattern of results could be that depression in adolescents
experiencing both depressive symptoms and comorbid externalizing problems might be the
direct consequence of the externalizing problems or of the lifestyle connected with externalizing
problems, as predicted by the so-called “failure model” (Capaldi & Stoolmiller, 1999). This
model suggests that externalizing problems can result in conflict with others, rejection, a lack of
support, poor skill development, and being difficult to teach, which in turn leads to failure
experiences in social interactions and academic achievement. Such stressful life experiences are
known to increase the risk of depression (Patterson & Stoolmiller, 1991). Furthermore, Panak
and Garber (1992) showed that peer rejection partially mediates the link between externalizing
problems and depressive symptoms. If our hypothesis is correct, the prevention of depressive
symptoms in adolescents with externalizing problems might reduce depressive symptoms on a
short-term basis, but in the long run, it will have only a reduced influence if changes are not
made in the externalizing behaviors that cause depressive symptoms in these adolescents.
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In general, some variables have to be considered when focusing on the prevention of
depressive symptoms in adolescents, beginning with gender. According to the literature, the
prevalence of major depression for adolescent girls is twice as high as it is for boys (e.g., Hankin
et al., 1998). Furthermore, concurrent and life-time comorbidity involving depression is higher in
girls than in boys (Costello et al., 2003), causing differences in the effects of prevention of
depressive symptoms based on the mechanisms proposed above.
Additionally, the so-called prevention effect and therapy effect have to be taken into account.
The term prevention effect refers to the prevention of the expected increase of depressive
symptoms in participating adolescents without symptoms or with less severe symptoms at
baseline. This effect becomes apparent as no changes in depressive symptoms occur in the
intervention group while depressive symptoms in the control group increase. Therapy effect,
however, refers to a decrease of symptoms in adolescents with more severe depressive symptoms
at baseline in the intervention group while the severity of depressive symptoms in the control
group remains stable or increases further. This theoretical pattern of results is supported by
empirical studies (e.g., Pössel, Horn, Hautzinger, & Groen, 2004).
Hypotheses
Based on the literature, it can be expected that universal prevention of depressive symptoms
will have positive effects on the depressive symptoms of participating adolescents (e.g., Merry et
al., 2004; Pössel, 2005; Shochet et al., 2001). In order to give further support to this assumption,
one aim of this study is to replicate these findings of universal prevention of depressive
symptoms. For adolescents without and with less severe depressive symptoms at baseline, we
expect to see a prevention effect with an increase in depressive symptoms in the control group,
but no changes in the depressive symptoms of the intervention group. This should lead to
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significant differences between both groups over time. In adolescents with elevated depressive
symptoms at baseline, a decrease in symptoms can be expected in the intervention group
(therapy effect). As with adolescents with few depressive symptoms at baseline, this should lead
to significant differences between the intervention and control groups over time. Nevertheless,
prevention is expected to be less effective in adolescents with comorbid anxiety symptoms
immediately after the program, and in adolescents who display comorbid externalizing problems
in follow-up assessments, than in adolescents without such symptoms.

Methods
Participants
Letters were sent to the principals of six middle schools in the area of Tuebingen (southwest
Germany), asking for their school’s participation in this project. The principals of two schools
refused participation, expressing concerns for the potential loss of lessons for their normal school
curriculum. A written description of the study was sent to the parents of the eighth graders at the
four participating schools. Additionally, the study was described in detail to the adolescents and
their parents in a parent-teacher conference by the authors. In these conferences the adolescents,
parents, and their class teachers discussed the participation of the class and decided together if
the class as a whole should participate in the study. As result of this procedure, all classes invited
to participate in the study decided to give consent. Furthermore, all parents and adolescents, not
participating on the parent-teacher conferences gave consent, too. This very high participation
rate is typical for universal prevention in a school system like the one in Germany (Pössel,
Baldus, Horn, Groen, & Hautzinger, 2005; Pössel, Horn, Hautzinger, & Groen, 2004), where
classes of up to 30 students are taking all of their school courses together, for all high-school
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years. Therefore, it is common that students have most of their friends in this one class, and they
are highly motivated to participate in the same activities as their classmates, like in the
prevention program.
Within the schools, the classes were randomly assigned to the intervention and control group.
Both intervention and control conditions were recruited in each school, so that one class was
randomly assigned to one condition and the other class was automatically assigned to the other.
As result of the randomization procedure, 163 students (72 girls) in six school classes
participated in the prevention program, and 138 students (68 girls) in six other classes received
school lessons as usual (non-intervention control group). Based on this sample size of 301
adolescents and the calculated effect sizes for the impact of comorbid symptoms reported in the
literature, this study design was adequate (>0.80) to detect medium or larger effect sizes (f2 =
0.07; Cohen, 1988) with 4-way interactions.
The mean age of the participants in the intervention condition was 13.73 years (SD = 0.63).
In the control condition the mean age was 13.63 years (SD = 0.58). Hereby, the age of the sample
is within the range of earlier studies with school-based prevention programs (e.g., Petersen,
Leffert, Graham, Alwin, & Ding, 1997; Clarke et al., 1993). During the course of the study
17/163 students of the intervention condition and 13/138 of the control condition dropped out
because they changed schools. There were no differences between the drop-outs and remaining
students in condition, (intervention vs. control), ²(1) = -0.47, p = .642, gender, ²(1) = -1.58, p =
.115, age, t(49.25) = 0.17, p = .867, and anxiety symptoms, t(299) = -0.82, p = .412. But dropouts showed more severe depressive symptoms, t(299) = -2.14, p = .033, and had higher
composite scores of externalizing problems, t(47.18) = -2.52, p = .015, than remaining students.
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Although data on socioeconomic status of the students are not available, a wide range of
social classes is likely to be represented because students from schools in economically different
regions of the area are represented.
Measures
The Self-report Questionnaire – Depression (Selbstbeurteilungsbogen-Depressive Störungen;
SBB-DES) is an instrument developed for children and adolescents. It measures the severity of
major depression and dysthymia symptoms outlined by the DSM-IV and ICD-10 (Döpfner &
Lehmkuhl, 2000). The SBB-DES consists of 26 items (e.g., “I am sad most of the time.”). Each
item has to be answered on a 4-point Likert scale, with higher numbers indicating more
accordance with the item (on a scale ranging from 0 = “Not at all” to 3 = “A lot”). The test score
is determined as the mean of the items, creating a range of scores from 0 to 3. Following Döpfner
and Lehmkuhl (2000) a value of > 1 represents relevant depressive symptoms. In our sample,
Cronbach’s Alpha = .92 and the 6 month test-retest stability, r(301) = .56, of this measure
reached adequate levels.
The Self-report Questionnaire – Anxiety (Selbstbeurteilungsbogen-Angststörungen; SBBANG) is an instrument developed for children and adolescents to measure severity of anxious
symptoms of GAD (e.g., “I am fearful of different events or have frequent worries (e.g., that I do
anything wrong or that something bad happens to me or someone else).”), social anxiety (e.g., “I
worry a lot about my behavior towards strangers.”), specific phobias (e.g., “I am very fearful of
animals like dogs, spiders, or mice although I know this anxiety is excessive and
unreasonable.”), and separation anxiety (e.g., “I am fearful of being separated from my parents.”)
outlined by the DSM-IV and ICD-10 (Döpfner & Lehmkuhl, 2000). The SBB-ANG consists of
26 items. Each item has to be answered on a 4-point Likert scale, with higher numbers indicating
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more accordance with the item (on a scale ranging from 0 = “Not at all” to 3 = “A lot”). The test
score is determined as the mean of all SBB-ANG items, creating a range of scores from 0 to 3.
Following Döpfner and Lehmkuhl (2000) a value of > 1 represents relevant anxious symptoms.
In our sample, Cronbach’s Alpha = .90 and the 6 month test-retest stability, r(301) = .62, of this
measure reached adequate levels.
The Strengths and Difficulties Questionnaire (SDQ, Woerner et al., 2002) is a brief
questionnaire to measure the psychological adjustment of 11 to 16 year-olds and may be
completed as a teacher or self-report measure. The SDQ consists of 25 positive and negative
attributes. Participants rated each item on a 3-point Likert scale describing their personal
strengths and difficulties (on a scale ranging from 0 = Not true to 2 = Certainly true). The items
are divided into 5 scales (emotional symptoms, conduct problems, hyperactivity, peer problems,
prosocial behavior) of 5 items each (e.g., “I get very angry and often lose my temper.”). Sum
score of each scale range from 0 to 10. The SDQ is translated into more than 40 languages and
can differentiate between normal adolescents and those with pathological symptoms, as well as
between different disorders just as well as the YSR with just a fifth of the items (e. g., Klasen et
al., 2000). In our sample, internal consistencies for the self-report scales of the SDQ were
between .63 and .80 (Cronbach’s ), and the internal consistencies for the teacher-reports were
between .73 and .85 (Cronbach’s ) which are comparable to internal consistencies of normative
data for a representative German population (Woerner et al., 2002). In our sample, the 6 month
test-retest stabilities of self- and teacher-reports are r(301) = .50 and r(293) = .73, respectively.
Finally, the correlations between self- and teacher-reports range between r(296) = .25 and r(296)
= .34, which is similar to correlations reported by Achenbach, McConaughy, and Howell (1987)
in their meta-analysis of cross-informant correlations. The SDQ conduct problems scores of
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adolescents and teachers were added to calculate a composite score for externalizing problems.
Based on the representative field study of Woerner et al. (2002) a value in this composite score <
8 represents no or minimal symptoms, a value of 8 represents threshold problems and values > 8
represent relevant externalizing problems.
The school-based prevention program
Our manualised school-based universal primary prevention program LARS&LISA (Pössel,
Horn, Seemann, & Hautzinger, 2004) is based on the social information processing model of
social competence as described by Dodge (1993). Methods used are taken from cognitivebehavioral therapy. Based on Dodge’s (1993) model, our prevention program targets on
cognitive and social aspects, which can be further differentiate as follows: a) Two sessions about
the relationship between cognition, emotion, and behavior; b) three sessions about exploration
and changing dysfunctional cognitions; c) two sessions of assertiveness training; and d) two
sessions of social competence training. The cognitive part of the program is based on the
cognitive therapy approach of Beck, Rush, Shaw, and Emery (1979). First, the trainers explain
the relationship between cognition, emotion, and behavior to the adolescents. Students then
acknowledge their own automatic thoughts, confront them with the reality, and finally substitute
them by functional, i.e., more realistic and helpful, thoughts. This part is designed to decrease
underlying dysfunctional cognitions and to increase functional cognitions. By doing so,
adolescents are expected to show less sadness, less anger, and more pleasure even with stressful
experiences like school and social rejection. Furthermore, it can be posited that students’ selfefficacy in social interactions increases as they develop functional cognitions. They frequent
social interactions and come to see them as a possible alternative against withdrawal.
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The social part of the program includes trainings for assertiveness and social competence. In
the assertiveness training, adolescents practice confident, assured behavior in various situations.
The social competence training targets the students’ abilities to develop and maintain social
contacts and networks. The training of new or unfamiliar functional behaviors in role plays leads
to increased recognition about their possible value as alternative behaviors. Positive
reinforcement during the program encourages adolescents’ positive evaluation of the adaptive
behavior beyond the program. Increasingly adaptive social behavior is expected as results of the
role plays enabling participating adolescents to develop their individual social network, to
enlarge it, and to improve using it.
Additionally, LARS&LISA includes a motivation section (one session) which is a main
improvement to the previous program (LISA-T: Pössel et al., 2005; Pössel, Horn, Hautzinger, &
Groen, 2004) and is gives students an opportunity to consider their goals and immediate plans of
action to achieve them. Based on these principles, the usefulness of the newly acquired skills is
shown at the end of every session. This procedure was developed in accordance to Kanfer and
Gaelick-Buys (1991) and was adapted to adolescents. All parts of the program use illustrative
situations introduced by the participating adolescents.
Design and Procedure
The impact of the prevention program LARS&LISA was determined by a prospective design
comparing an intervention and a control condition. The questionnaires were filled in by the
adolescents and their class teachers at baseline, immediate post-intervention, and 6-month
follow-up. LARS&LISA was administered once a week over a 10-week period during regular
school hours. One session comprised two class periods with a total of 1.5 hours each. During this
time the control classes attended their usual school lessons, because of this design adolescents
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and teacher knew about the assignment of the students to the intervention or non-intervention
control group. Intervention classes were conducted separately by gender, because adolescents
may be hesitant to portray themselves authentically in front of peers of the opposite gender. In
fact, a pilot study has shown that adolescents in this age group work more effectively and openly
as a team if they participate in gender homogenous groups (Pössel, Horn, & Hautzinger, 2003).
Adolescents, parents, and teachers of intervention and control group were informed about the
program’s objectives to strengthen skills of the adolescents and to facilitate their coping with
strains. It was explained that having a control group is essential in order to study the program’s
effects. The study was approved by the ethical committee of the German Psychological
Association. Each intervention group was coached by a trainer and a co-trainer, who were either
master level psychologists or graduate students experienced in working with adolescents. As the
majority of trainers and co-trainers were female (female = 5, male = 3), it was not possible to fit
their gender to the gender of the adolescents. To minimize effects of the trainer’s gender,
trainers/co-trainers worked in gender mixed teams. Special training was provided for all trainers
in three steps. First, each future trainer went through the program as participant. Secondly, they
studied the manual, all materials and procedures, and resolved unclear points with the first
author. Finally, they led a group as co-trainer together with a more experienced trainer.
Furthermore, supervision was provided for all trainers with the help of video recordings of each
session and a 1.5-hour weekly meeting with the first author. These recordings were also used to
ensure that trainers adhered to the LARS&LISA manual.
Data Analysis
To test the influence of the postulated factors separately hierarchical linear model analyses
were calculated with anxiety, and the composite externalizing problems scale. Interactions
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between students of the same class or school may lead to intercorrelation of variables and create
a general methodological problem in school-based studies (Hopkins, 1982). Disregarding
potential nuisance variables may cause misinterpretations of results because natural groups, such
as classes, as well as reciprocal influences between individuals and group, leading to enhanced
group-specific differences between individuals (Goldstein, 1995). Therefore, a 2-level model
was calculated with students nested within classes. School was not considered a group variable
because both experimental conditions were administered to each participating school.
SBB-DES score at baseline, gender of the students (dummy variable: boys = 0, girls = 1),
comorbidity (SBB-ANG score or combined SDQ conduct behavior score), and intervention
condition (dummy variable: control group = 0, intervention group = 1) as well as all possible
interactions between these factors were entered as independent variables. The SBB-DES score at
post-intervention was used as dependent variables in two HLM analyses and at 6-month followup in further two analyses. Because the four-way interactions did not explain significant variance
in either of the analyses, these interaction analyses are not presented.
In order to examine interactions relevant for the hypotheses, residual change scores (RCS)
for high and low depressed participants were calculated following the suggestions by Cohen,
Cohen, West, and Aiken (2003). These RCS enable a graphical presentation of direction and
height of the changes in depressive scores from baseline to post-intervention or to 6-month
follow-up. In order to differentiate between high and low depressed participants a median-split
was performed with the SBB-DES score at baseline.
Furthermore, effect sizes following Hedges’s g [= (mean of one group - mean of the other
group) divided by pooled standard deviation of both groups] and their 95% confidence interval
were calculated (Cohen, 1988). Effect sizes are displayed as positive values when the severity of
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depressive symptoms decreased over time or when the intervention condition shows lower
depression scores as the control condition. A comparison is stated to be only significant when the
confidence interval of the effect size does not include null.

Results
Pre-intervention Comparisons
No significant differences between the conditions were found for self-reported depressive,
t(299) = -0.97 , p = .334, and anxiety, t(299) = 1.09 , p = .276, symptoms at baseline, composite
externalizing problems at baseline, t(294) = 1.41, p = .161, and gender, ² (1) = -0.88, p = .377.
It is of further interest that depressive and anxiety symptoms reported by the participants cover
almost the whole range of the scales (depression score: 0.00 to 2.50; anxiety score: 0.00 to 1.90).
These data indicate the representation of depressive and anxiety symptoms on all severity levels
in the sample. This contrasts the data for the composite externalizing problems, where more
severe scores are not represented in the sample (Range: 0 to 15). The descriptive statistics are
shown in Table 1. Furthermore, correlations between self-reported depressive and anxious
symptoms as well as the composite externalizing problems at all time points are reported in
Table 2.
Intervention Effects with anxiety symptoms
In the post-intervention HLM analysis with comorbid anxiety symptoms the main effect of
gender and condition, as well as the expected two-way interaction of baseline depressive
symptoms by condition were significant. In the 6-month follow-up analysis the main effect of
gender, as well as the two-way interactions of baseline depressive symptoms by gender and
baseline depressive symptoms by condition were significant. None of the other main or
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interaction effects were significant. Especially anxiety symptoms have no impact on the effect of
the prevention program (Table 3).
Based on the calculated effect sizes and visualized in figure 1 depressive symptoms in
adolescents with less severe depressive symptoms at baseline in the control group increased from
baseline to post-intervention, g = -0.84, 95%; CI for effect size = - 1.19 to - 0.48, and from
baseline to 6-month follow-up, g = -0.73, 95%; CI for effect size = - 1.07 to - 0.39. In the
intervention group the depressive symptoms increased from baseline to 6-month follow-up, g = 0.43, 95%; CI for effect size = - 0.76 to - 0.11, only. Furthermore, while adolescents with less
severe depressive symptoms at baseline in the intervention group report significantly more
severe depressive symptoms than their peers in the control group at baseline, g = 0.35, 95%; CI
for effect size = 0.01 to 0.69, no significant difference between students in both conditions can
be shown at post-intervention, g = -0.29, 95%; CI for effect size = -0.64 to 0.05, or 6-month
follow-up, g = 0.11, 95%; CI for effect size = -0.23 to 0.44. Finally, depressive symptoms in
adolescents with less severe depressive symptoms at baseline in the control group increase
significantly more than symptoms in adolescents in the intervention group from baseline to postintervention, g = 0.38, 95%, CI for effect size = 0.03 to 0.72. These results are mostly consistent
with the posited prevention effect in adolescents with less severe depressive symptoms at
baseline.
Intervention effects with composite externalizing problems
In the post-intervention HLM analysis with composite externalizing problems the main effect
of depressive symptoms at baseline and externalizing problems, as well as the expected two-way
interaction of depressive symptoms at baseline by condition and the three-way interaction of
depressive symptoms at baseline by gender by condition were significant. In the 6-month follow-
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up analysis only the three-way interaction of depressive symptoms at baseline by gender by
condition reached significance. None of the other main or interaction effects were significant.
Especially the composite externalizing problem scores have no impact on the effect of the
prevention program (Table 4).
From baseline to post-intervention as well as to 6-month follow-up the depressive symptoms
increased significantly in boys with less severe depressive symptoms at baseline in the control
group (baseline – post-intervention: g = -1.29, 95%; CI for effect size = - 1.80 to - 0.79; baseline
– 6-month follow-up: g = -0.93, 95%; CI for effect size = - 1.40 to - 0.45) as well as in the
intervention group (baseline – post-intervention: g = -0.60, 95%; CI for effect size = - 1.03 to 0.18; baseline – 6-month follow-up: g = -0.56, 95%; CI for effect size = - 0.97 to - 0.15).
Nevertheless, boys with less severe depressive symptoms at baseline in the intervention group
report significantly more severe depressive symptoms than their peers in the control group at
baseline, g = 0.53, 95%; CI for effect size = 0.06 to 1.00. No significant difference can be shown
between both conditions at post-intervention, g = 0.40, 95%; CI for effect size = -0.07 to 0.87, or
6-month follow-up, g = 0.15, 95%; CI for effect size = -0.29 to 0.60. Finally, depressive
symptoms in boys with less severe depressive symptoms at baseline in the control group increase
significantly more than symptoms in boys in the intervention group from baseline to postintervention, g = 0.51, 95%, CI for effect size = 0.04 to 0.98. Like in the analyses with comorbid
anxiety, these results are mostly consistent with the posited prevention effect in boys with less
severe depressive symptoms at baseline.
In boys with more severe depressive symptoms at baseline, however, the severity of
depressive symptoms increased significantly in the intervention group (baseline – postintervention: g = -0.43, 95%; CI for effect size = - 0.85 to - 0.01; baseline – 6-month follow-up:

Impact of comorbidity on prevention 19
g = -0.50, 95%; CI for effect size = - 0.95 to - 0.05) while the self-reported severity of depressive
symptoms in the control group showed no significant changes. This result is contrary to the
posited therapy effect in boys with more severe depressive symptoms at baseline. These results
are attenuated by the lack of significant differences between boys with more severe baseline
depressive symptoms at any time point.
Unlike the results in boys, the severity in depressive symptoms decreased significantly in
girls with less severe depressive symptoms at baseline in the intervention group from baseline to
post-intervention, g = 0.61, 95%; CI for effect size = 0.09 to 1.13, and in girls with more severe
depressive symptoms at baseline in the intervention group from baseline to 6-month follow-up, g
= 0.52, 95%; CI for effect size = 0.08 to 0.95. Contrary to these improvements in the intervention
group, the depression scores in girls the control group showed no significant changes over time
and girls did not differ between both conditions at any time point (Figure 2). Nevertheless,
depressive symptoms in girls with less severe depressive symptoms at baseline in the control
group increase significantly more than symptoms in girls in the intervention group from baseline
to post-intervention, g = 0.52, 95%, CI for effect size = 0.02 to 1.01. These results provide
mostly evidence for a therapy effect in girls, independent of their depressive symptoms at
baseline.

Discussion
In adolescents with less severe depressive symptoms at baseline participating in
LARS&LISA no increase in the severity of self-reported depressive symptoms from baseline to
post-intervention could be observed. Beyond this, depressive symptoms increase significantly
less in these adolescents than in adolescents in the control group. In the long-term, increase in the
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severity of depressive symptoms in these adolescents is reduced from baseline to follow-up
while depression scores in the control group increase significantly from baseline to postintervention and from baseline to follow-up. Furthermore, a significant difference between
adolescents with less severe depressive symptoms at baseline in both conditions at baseline is
leveled out at the later time points by this increase in the severity of self-reported depressive
symptoms in the control group. These results are mostly in line with the expected prevention
effect and findings of the previous prevention program (Pössel, Horn, Hautzinger, & Groen,
2004; Spence et al., 2003).
Focusing on gender, these positive effects on self-reported depressive symptoms in the
intervention group based in part on boys with less severe depressive symptoms at baseline and
especially on girls mostly independent of their depressive symptoms at baseline. The increase in
depressive symptoms in boys with less severe depressive symptoms at baseline in the
intervention group is reduced compared to the non-intervention control group. Furthermore,
depressive symptoms in boys with less severe depressive symptoms at baseline in the
intervention group increase significantly less than in adolescents in the control group from
baseline to post-intervention. Finally, the difference between these boys in both conditions at
baseline is leveled out at the later time points by an increase in depressive symptoms in the
control group. Finally, the severity of depressive symptoms in girls with less severe depressive
symptoms at baseline are even significantly reduced from baseline to post-intervention as well as
in girls with more severe depressive symptoms at baseline from baseline to follow-up. These
results are partially in line with the expected prevention and therapy effect. Moreover, the shortterm reduction in the severity of depressive symptoms in girls with less severe depressive
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symptoms at baseline exceeds the expectations and earlier results (Pössel, Horn, Hautzinger, &
Groen, 2004).
Contrasting earlier results depression in boys with more severe depressive symptoms at
baseline increases over time in the intervention group while no such change could be observed in
control group boys with more severe depressive symptoms at baseline. Nevertheless, it has to be
considered that gender was not used as independent variable in the evaluation studies of the
previous program (LISA-T: Pössel, Horn, Hautzinger, & Groen, 2004; Pössel et al., 2005). In the
literature, however, seven studies focus on the impact of gender on the effects of prevention of
depressive symptoms. While in some studies no gender effect was found (Chaplin et al., 2006;
Clarke et al., 1993, 2nd study; Merry et al., 2004; Shochet et al., 2001), in others studies boys
(Clarke et al., 1993, 1st study; Shatte, 1996) or girls (Gillham, Hamilton, Freres, Patton, &
Gallop, 2006; Petersen et al., 1997), respectively, benefit more than the other gender from
participating in the prevention programs. The gender effect seems to be independent of the type
of the program (universal vs. selective), topics of the program (educational, cognitive, social,
cognitive & social), age of the students (6th to 10th grade), time of assessment (post-assessment to
24-month follow-up), and gender composite of the groups (co-ed vs. gender homogenous).
Chaplin et al. (2006), for example, found no gender effect in their study with students from 6th to
8th grade while Shatte (1996) and our study found a gender effect in 7th and 8th grade students,
respectively. These contradictory results do not support the idea that differences in the
development (cognitive development, maturational status) are responsible for gender differences
in prevention programs. Furthermore, our study demonstrates that gender effects exist not only in
co-ed groups (e.g., Petersen et al., 1997) but in gender homogeneous groups, too. Finally,
Chaplin et al. (2006) found no difference in the effect of prevention on depressive symptoms in
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girls depending on their participation in co-ed or girls-only groups, which reduces the likelihood
that the separation of the adolescents by gender is responsible for the gender effect in our study.
So far no explanation for the partially obvious gender effect exists, so that research focusing on
possible mediators and moderators is needed.
Furthermore, the increase in the severity of depressive symptoms in boys contrasting stable
values in girls in the non-intervention control group is of interest as this result is opposed to most
studies which show decreased depression scores in boys and increased depression scores in girls
(e.g., Angold, Erkanli, Silberg, Eaves, & Costello, 2002). Yet, Ge, Lorenz, Conger, Elder, and
Simons (1994) found stable depressive symptoms in boys and increased scores in girls in their 4year longitudinal study. Hankin et al. (1998) showed an increase of lifetime prevalence and new
diagnosed disorders of major depression in both gender between 15 and 18 years. Finally,
Reivich (1996) reported a decrease of self-reported depressive symptoms in girls and stable
values in boys of the non-intervention control group in the initial evaluation study of the Penn
Resilience Program. Up to now, reasons for these differences between the studies remain
unclear. Hankin et al. (1998) suggest the use of different instruments as cause for different
gender effects, which is supported by the literature because the studies that used diagnoses and
self-ratings of the severity of depressive symptoms (Ge et al., 1994; Hankin et al., 1998; Reivich,
1996) found stable symptoms or a (temporary) increase of depression in boys while the studies
that used self-ratings of the frequency of depressive symptoms (Angold et al., 2002) found
decreasing symptoms in boys.
Contrary to the expectations the effects of the cognitive-behavioral prevention program are
independent from self- and teacher-reported comorbidity in adolescents at both post-intervention
and 6-month follow-up. Neither anxiety symptoms nor externalizing problems seem to have an
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impact on the effects of the prevention program. Similar results were found in some previous
psychotherapy studies in depressed adolescents (Brent et al., 1998; Rohde et al., 2001; Weersing
& Weisz, 2002).
One explanation for these results might be that the link between depression and externalizing
problems in adolescents constitutes a depressogenic attribution style. Toth, Cicchetti, and Kim
(2002), for example, have suggested a global and internal attribution of negative events to cause
frustration which could be expressed as aggressive behavior. Similar relations of depressogenic
attributional style to externalizing problems and to depression support this hypothesis (Hankin &
Abramson, 2002). Other studies, however, found that depressogenic attributional style predicts
depression but not externalizing (e.g., Robinson, Garber, & Hilsman, 1995). Furthermore, minors
with depressive and externalizing symptoms show distinct differences in the attributions they
tend to make regarding social situations (Dodge, 1993). Finally, Toth et al’s. (2002) theory can
not explain why some previous studies found that externalizing problems reduce the long-term
effects of cognitive-behavioral therapy (Brent et al., 1999; Rohde et al., 2001; Rohde, Clarke et
al., 2004) while no comparable influence on the effects of the prevention program was described
although the program used methods taken from cognitive-behavioral therapies.
It has to be considered that most studies focusing on the influence of comorbid mental
disorders used clinician-reports to assess the comorbid problems while in the present study
externalizing problems were measured by a composite score of self- and teacher-report and
anxiety symptoms were measured by self-report only. It is unknown if and how these different
informants may be a cause of different results.
The sample size in the current study can be another possible explanation for the absence of
an impact of comorbid symptoms. The calculated sample size based upon 6 of 20 comparisons
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reported in the literature and is adequate only to detect medium or larger effect sizes (f2 = .07) in
the total sample size of 301 adolescents. It is possible that the impact of comorbid symptoms is
smaller in the excluded comparisons. This leads to an overestimation of the real impact of
comorbid symptoms, which might be more in the area of small to medium effect sizes. As
consequence, the calculated sample size in the presented study might be too small to detect the
impact of comorbid symptoms. Another possible explanation for the lack of an observable
impact of comorbid symptoms, especially regarding externalizing problems, might be that
adolescents who dropped out show significantly higher composite externalizing problems scores
compared to those who remained in the study. It is likely that those adolescents most at risk to
inhibit positive effects because of comorbid problems are not available in the follow-up
assessment. Furthermore, a limited severity of anxiety symptoms as well as externalizing
problems might be another reason why both comorbid symptoms have no impact on the effects
of the prevention program on depressive symptoms. Contrary to this possible explanation anxiety
symptoms reported by the participants cover almost the whole range of the used scale, so that all
severity levels seem to be represented in the sample. For the composite externalizing problems,
however, the more severe scores are not represented in the sample. Nevertheless, with a range of
0 to 15 the composite score includes relevant problems (> 8) as well. Furthermore, the mean of
the same composite score of externalizing problems in a clinical sample is 5.8 (Becker,
Hagenberg, Roessner, Woerner, Rothenberger, 2004). All these data do not support the idea of
limited severity anxiety symptoms and externalizing problems being responsible for the lack of
impact on the effects of the prevention program. At least, it has to be taken under consideration
that previous studies reported just 24-month follow-ups while up to now the present study
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includes only a follow-up after six month. It might be that externalizing problems have a more
long-term influence.
Certain limitations of this study may have suppressed potential intervention effects. The most
important limitation is the absence of any formal intervention as control condition. Although this
is very common in prevention research (e.g., Clarke et al., 1993; Gillham, Reivich, Jaycox, &
Seligman, 1995) this problem should not be neglected. Thus, it is unclear whether the findings
are specific or only due to an attention effect. The situation is even more complex because the
adolescents and their teachers knew about the assignment of the students to the intervention or
non-intervention control group due to the fact that common school lessons take place in the
control group. This may have influenced the answers of both, adolescents and teachers.
However, if this is true the effects should be similar for both genders, but the findings show
different effects for girls and boys.
Another limitation is the exclusive usage of self-reports for the measurement of depressive
symptoms. Demand characteristics may have led adolescents in the intervention condition to
infer desired answers from the content of the intervention. However, previous studies have
demonstrated adolescents to be a reliable source of information for internalization disorders such
as depression (Inderbitzen, 1994), and self-reports of adolescent behavior to be valid
measurements (Hops, Alpert, & Davis, 1997). Finally, depression self-report has a high
predictive validity (Gotlib, Lewinsohn, & Seeley, 1995). Nevertheless, additional information
from teacher, parents, or behavioral observations should be integrated in future research.
Despite these limitations it has to be considered that this is the first study focusing on the
influence of comorbidity in prevention of depressive symptoms. Another advantage is the low
drop-out rate of approximately 10% and no recruiting difficulties which support a high
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generalization of the results. Finally, the use of teacher as source for information about the
externalizing symptoms is advantageous, as adolescents are proven to be less useful informants
to measure this symptomatology (Ford, Goodman, & Meltzer, 2003).
Clinical Implications
In sum, girls independent of their baseline depression showed a significantly decrease in the
severity of self-reported depressive symptoms and in boys with less severe depressive symptoms
at baseline an increase in the severity of depressive symptoms could be reduced. Furthermore, a
significant difference in the severity of depressive symptoms at baseline between these boys in
both conditions could be leveled out by the increase in severity of depressive symptoms in boys
in the non-intervention control group. Unexpectedly, boys with more severe depressive
symptoms at baseline in the intervention group reported an increase in the severity of depressive
symptoms while no change could be observed in control group boys with more severe depressive
symptoms at baseline. However, no significant difference between boys in intervention and
control condition could be shown. Contrary to the hypotheses, the effect of the prevention
program on depressive symptoms is not influenced by anxiety or externalizing symptoms. The
low drop-out rate and high recruiting rate support the generalizability of the results. Based on the
study results, we conclude that the school-based cognitive-behavioral prevention program
LARS&LISA has favorable effects in adolescents. Nevertheless, we recommend refraining from
including boys with more severe depressive symptoms at baseline in the training until the causes
and mechanisms of negative intervention effects are understood.
The implementation of the studied prevention program in schools within the usual school
curriculum remains an important challenge. Therefore, it seems crucial to reduce the number of
trainer needed to implement the groups in LARS&LISA. Addressing this issue, a study testing
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the effects of LARS&LISA in gender homogenous groups led by only one trainer is in
preparation.
Moreover, the profession of the future trainer is a relevant issue with regard to the
implementation of the program in regular school curricula, as it is not feasible to permanently
deploy external psychologists. However, recent studies show that the effect size of an Australian
prevention program of depressive symptoms is only about half of the size when groups are led by
teacher (Merry et al., 2004) compared to groups led by psychologists (Shochet et al., 2001).
Although the reasons for this difference are unclear up to now, this result supports the idea not to
focus on teachers, but on school counselors as trainer in future research.
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Table 1: Descriptive statistics of the intervention and non-intervention control group
Intervention group

Control group

boys (n = 91)

girls (n = 72)

boys (n = 70)

girls (n = 68)

M (SD)

M (SD)

M (SD)

M (SD)

13.74 (.66)

13.72 (.59)

13.67 (.58)

13.59 (.58)

SBB-DES baseline

.51 (.42)

.70 (.50)

.52 (.46)

.56 (.41)

SBB-DES post-intervention

.73 (.65)

.57 (.49)

.75 (.62)

.57 (.47)

SBB-DES 6-month follow-up

.67 (.66)

.55 (.48)

.67 (.66)

.58 (.45)

SBB-ANG baseline

.42 (.37)

.54 (.37)

.45 (.39)

.60 (.32)

4.03 (2.60)

3.20 (2.45)

4.41 (2.85)

3.76 (2.39)

Age

composite externalizing
problems baseline

Note. SBB-DES = Self-report Questionnaire – Depression; SBB-ANG = Self-report
Questionnaire – Anxiety; composite externalizing problems = adolescent SBQ conduct behavior
+ adolescent SBQ conduct behavior
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Table 2: Correlations between depressive symptoms, anxious symptoms, and externalizing symptoms at all three time points
1
1 SBB-DES baseline
2 SBB-ANG baseline
3 composite externalizing problems baseline
4 SBB-DES post-intervention
5 SBB-ANG post-intervention
6 composite externalizing problems post-intervention
7 SBB-DES 6-month follow-up
8 SBB-ANG 6-month follow-up
9 composite externalizing problems 6-month follow-up

2

3

4

5

6

7

8

9

.69**

.23**

.53**

.40**

.18**

.41**

.37**

.23**

.13*

.36**

.36**

.01

.37**

.39**

.08

.29**

.29**

.72**

.19**

.21**

.71**

.81**

.35**

.56**

.58**

.26**

.35**

.56**

.62**

.27**

.21**

.18**

.73**

.88**

.20**
.17**
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Table 3: HLM analyses with comorbid anxiety symptoms
post-intervention

6-month follow-up

Estimate

SE

t

Estimate

SE

t

baseline depression

.29

.28

1.05

-.14

.30

-0.45

anxiety symptoms

.14

.29

0.48

.27

.31

0.88

gender

-.40

.20

-2.01*

-.45

.22

-2.00*

condition

-.39

.16

-2.48*

-.30

.17

-1.72

baseline depression by condition

.83

.33

2.52*

.87

.37

2.36*

baseline depression by anxiety symptoms

-.01

.22

-0.04

.44

.27

1.63

baseline depression by gender

.31

.38

0.81

.89

.43

2.06

anxiety symptoms by gender

-.19

.38

-0.49

.11

.42

0.25

anxiety symptoms by condition

.27

.38

0.72

.28

.43

0.66

condition by gender

.18

.20

0.87

.05

.23

0.23

baseline depression by anxiety by condition

-.52

.29

-1.82

-.69

.36

-1.93

baseline depression by gender by condition

-.57

.36

-1.59

-.63

.41

-1.55

anxiety symptoms by gender by condition

.08

.43

0.19

.30

.47

0.63

baseline depression by anxiety symptoms by gender

.31

.30

1.04

-.68

.37

-1.85

Note. * = p  .05; df = 258 for all analyses with post-intervention; df = 260 for all analyses with 6-month follow-up (only exception is the main
effect condition with df = 10)
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Table 4: HLM analyses with comorbid externalizing problems
post-intervention

6-month follow-up

Estimate

SE

t

Estimate

SE

t

baseline depression

.48

.14

2.27*

.47

.28

1.66

externalizing problems

.09

.21

3.52*

.03

.03

0.97

gender

-.19

.03

-0.92

-.22

.23

-0.94

condition

-.06

.20

-0.29

.09

.21

0.42

baseline depression by condition

.67

.32

2.12*

-.01

.37

-0.03

baseline depression by externalizing problems

-.03

.03

-1.08

.00

.04

0.11

baseline depression by gender

.53

.32

1.66

.57

.39

1.46

externalizing problems by gender

-.08

.04

-1.94

-.01

.05

-0.25

externalizing problems by condition

-.05

.04

-1.27

-.06

.04

-1.49

condition by gender

.04

.22

0.19

.03

.24

0.13

baseline depression by externalizing by condition

-.02

.05

-0.47

.08

.05

1.43

baseline depression by gender by condition

-.79

.27

-2.89*

-.67

.33

-2.05*

externalizing problems by gender by condition

.06

.05

1.31

.06

.05

1.10

baseline depression by externalizing by gender

.02

.05

0.40

-.06

.05

-1.19

Note. * = p  .05; df = 253 for all analyses with post-intervention; df = 253 for all analyses with 6-month follow-up (only exception is the main
effect condition with df = 10)
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Figure 1: Based on the regression analyses with anxiety symptoms RCS on the SBB-DES as a
function of depressive symptoms by condition interaction are present. Black bars denote low
baseline depression adolescents (SBB-DES scores  .4615); white bars denote high baseline
depression adolescents (SBB-DES scores > .4615). In the upper part RCS from baseline to postintervention and in the lower part RCS from baseline to 6-month follow-up are presented.

Figure 2: Based on the regression analyses with composite externalizing scores RCS on the
SBB-DES as a function of depressive symptoms by gender by condition interaction are present.
Black bars denote low baseline depression adolescents (SBB-DES scores boys > .4231; SBBDES scores girls > .50); white bars denote high baseline depression adolescents. In the upper part
RCS from baseline to post-intervention and in the lower part RCS from baseline to 6-month
follow-up are presented.
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